New clinical trials policy at FDA

被引：14
|
作者：
Vastag, Brian
机构：
来源：
NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 09期
关键词：
D O I：
10.1038/nbt0906-1043
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：1043 / 1043
页数：1
相关论文
共 50 条
  • [1] New clinical trials policy at FDA
    Brian Vastag
    Nature Biotechnology, 2006, 24 : 1043 - 1043
  • [2] New FDA Regulation to Improve Safety Reporting in Clinical Trials
    Sherman, Rachel Behrman
    Woodcock, Janet
    Norden, Janet
    Grandinetti, Cheryl
    Temple, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (01): : 3 - 5
  • [3] CONTROLLED CLINICAL TRIALS AND FDA
    SIMMONS, HE
    NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (20): : 1047 - &
  • [4] FDA POLICY ON WOMEN IN DRUG TRIALS - REPLY
    KESSLER, DA
    MERKATZ, RB
    TEMPLE, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (24): : 1815 - 1816
  • [5] US FDA announces new rules on safety during clinical trials
    不详
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (11) : 1626 - 1626
  • [6] FDA to oversee reporting of clinical trials
    Mark Ratner
    Nature Biotechnology, 2012, 30 : 1163 - 1163
  • [7] FDA to oversee reporting of clinical trials
    Ratner, Mark
    NATURE BIOTECHNOLOGY, 2012, 30 (12) : 1163 - 1163
  • [8] New journal policy regarding registration of clinical trials
    Stone, JH
    Lockshin, MD
    Katz, PP
    Yelin, EH
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (04): : 484 - 487
  • [9] Editorial - New policy on reports of randomized clinical trials
    Kaplan, RM
    Trudeau, KJ
    Davidson, KW
    ANNALS OF BEHAVIORAL MEDICINE, 2004, 27 (02) : 81 - 81
  • [10] New journal policy regarding registration of clinical trials
    Stone, JH
    Lockshin, MD
    Katz, PP
    Yelin, EH
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2243 - 2247
12345